{{NoteTA|G1=生命科学}}
{{medical}}
{{expand|time=2011-12-22}}
{{chembox
| Verifiedfields = changed
| verifiedrevid = 408768294
| ImageFile_Ref = {{chemboximage|correct|??}}
| ImageFile = Nicotinamide structure.svg
| ImageSize = 150px
| IUPACName = pyridine-3-carboxamide
| OtherNames = 3-pyridinecarboxamide<br/>niacinamide<br />nicotinamide<br/>nicotinic acid amide<br />Vitamin PP
| Section1 = {{Chembox Identifiers
| PubChem = 936
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 25X51I8RD4
| InChI1 = 1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9)
| InChIKey1 = DFPAKSUCGFBDDF-UHFFFAOYAZ
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1140
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = DFPAKSUCGFBDDF-UHFFFAOYSA-N
| CASNo_Ref = {{cascite|correct|CAS}}
| CASNo = 98-92-0
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 911
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00036
| InChI = 1/C6H6N2O/c7-6(9)5-2-1-3-8- 4-5/h1-4H,(H2,7,9)/f/h7H2
| EINECS = 202-713-4
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB02701
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 17154
| SMILES = c1cc(cnc1)C(=O)N
}}
| Section2 = {{Chembox Properties
| MolarMass = 122.12
| C=6|H=6|N=2|O=1
| Appearance = 
| Density = 
| MeltingPt = 128-131 °C
| BoilingPt = }}
| Section3 = {{Chembox Hazards
| Solubility = 
| MainHazards = 
| FlashPt = 
| Autoignition = }}
}}
'''烟酰胺'''（{{lang-en|Nicotinamide}}）是[[烟酸|烟酸]]（维生素B<sub>3</sub>）的[[酰胺|酰胺]]。主要用于防治糙皮并口炎、舌炎，病态窦房结综合征，房室传导阻滞等问题。烟酰胺是一种水溶性[[维生素|维生素]]且是[[B族维生素|维生素B]]族中的一员。烟酸可以[[in_vivo|在活体内]]被转变为烟酰胺，尽管这两种[[化合物|化合物]]都具有[[维生素效应|维生素效应]]，但烟酰胺较[[烟酸|烟酸]]的药理学与毒性要小，这些效应会在烟酸的转变过程中产生。因此烟酰胺也不会像烟酸一样减少[[胆固醇|胆固醇]]或导致脸潮红<ref>Jacenollo, P. (1992). [http://www.pubmedcentral.nih.gov/pagerender.fcgi?artid=1336277&pageindex=1 Niacin versus niacinamide]</ref>。当成人每天摄入剂量多于3g时，会对[[肝脏|肝脏]]产生毒性<ref name="Knip M, Douek IF, Moore WP, et al. 2000 1337–45">{{cite journal |author=Knip M |title=Safety of high-dose nicotinamide: a review |journal=Diabetologia |volume=43 |issue=11 |pages=1337–45 |year=2000 |pmid=11126400 | doi = 10.1007/s001250051536 |author-separator=, |author2=Douek IF |author3=Moore WP |display-authors=3 |last4=Gillmor |first4=H. A. |last5=McLean |first5=A. E. M. |last6=Bingley |first6=P. J. |last7=Gale |first7=E. A. M. |author8=European Nicotinamide Diabetes Intervention Trial Group}}</ref>。在细胞中，烟酸被用于合成[[烟酰胺腺嘌呤二核苷酸|烟酰胺腺嘌呤二核苷酸]]（NAD）与[[烟酰胺腺嘌呤二核苷酸磷酸|烟酰胺腺嘌呤二核苷酸磷酸]]（NADP），而对于烟酰胺来说转变途径与烟酸的途径非常相似。NAD<sup>+</sup>与NADP<sup>+</sup>是多种酶促[[氧化还原|氧化还原]]反应的[[辅酶|辅酶]]<ref name=Belenky>{{cite journal | author=Belenky P | coauthors=Bogan KL, Brenner C | title=NAD+ metabolism in health and disease | journal=Trends Biochem. Sci. | volume=32 | issue=1 | pages=12–9 | year=2007 | pmid=17161604 | url=http://www.dartmouth.edu/~brenner/belenky07a.pdf | accessdate=2007-12-23 | doi=10.1016/j.tibs.2006.11.006}}</ref>。

==参考文献==
{{reflist}}

==外部链接==
* {{ATC|A11|HA01}}
* [http://www.drugbank.ca/drugs/DB02701 DrugBank.ca Drug Card for Nicotinamide]

{{Vitamin}}
{{抗痤疮制剂}}
{{Melatonergics}}

[[Category:酰胺|Category:酰胺]]
[[Category:嘧啶|Category:嘧啶]]
[[Category:维生素|Category:维生素]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[category:煙酰胺|category:煙酰胺]]